Sunday, November 14, 2010

J&J's Natrecor - damned with faint praise - Robert Langreth - Treatments - Forbes

The drug does not have a long-term effect on clinical outcomes one way or another,” says Robert Califf of Duke University, who presented the big new study of 7000 patients at a news conference here at a meeting of the American Heart Association in Chicago.

Posted via email from Jack's posterous

No comments: